Sponsor pipeline

Innovent Biologics (Suzhou) Co. Ltd. clinical trial pipeline

Get alerts when Innovent Biologics (Suzhou) Co. Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

5 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 3 with minor changes only.

Show 3 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-25 NCT07842497 A Study of Efficacy and Safety of IBI3011 in Subjects With Acute Gouty Arthritis Phase 2 Not Yet Recruiting
2026-09-24 NCT07838220 A Study of IBI3016 in Japanese Participants Phase 1 Recruiting
2026-09-23 NCT07836660 A Study of IBI355 in Participants With Moderate-to-Severe Sjögren's Disease Phase 2 Not Yet Recruiting

Active trials by phase

Phase 1
21
Phase 1/2
6
Phase 2
17
Phase 3
15
Phase 4
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 18

Lung Cancer (10) · Obesity (9) · Non-Small Cell Lung Cancer (NSCLC) (8) · Atopic Dermatitis (4) · Hypertension (3) · Melanoma (3) · Multiple Myeloma (3) · Colorectal Cancer (2) · NASH / MASH (2) · Ovarian Cancer (2)

Get alerts when Innovent Biologics (Suzhou) Co. Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free